Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories total Scope 1 + Scope 2 Greenhouse Gas Emissions — Market-Based (ktCO2e)
Abbott Global Sustainability Reports (2019–2024)
Latest, FY2024
894
Period ended Dec 31, 2024
Change on a year earlier
-1.1%
904 in FY2023
History
9 years
Since FY2016
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Scope 1 + Scope 2 Greenhouse Gas Emissions — Market-Based (ktCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 894 | -1.1% | Abbott 2024 Global Sustainability Report ↗ |
| FY2023 | Dec 31, 2023 | 904 | -3.0% | Abbott 2024 Global Sustainability Report ↗ |
| FY2022 | Dec 31, 2022 | 932 | -0.1% | Abbott 2024 Global Sustainability Report ↗ |
| FY2021 | Dec 31, 2021 | 933 | +3.6% | Abbott 2022 Global Sustainability Report ↗ |
| FY2020 | Dec 31, 2020 | 901 | -6.4% | Abbott 2022 Global Sustainability Report ↗ |
| FY2019 | Dec 31, 2019 | 963 | -2.4% | Abbott 2022 Global Sustainability Report ↗ |
| FY2018 | Dec 31, 2018 | 987 | -1.6% | Abbott 2024 Global Sustainability Report ↗ |
| FY2017 | Dec 31, 2017 | 1,003 | -10.4% | Abbott 2019 Global Sustainability Report ↗ |
| FY2016 | Dec 31, 2016 | 1,120 | – | Abbott 2019 Global Sustainability Report ↗ |
Breakdown
What makes up total scope 1 + scope 2 greenhouse gas emissions — market-based (ktco2e)
- Total Scope 1 + Scope 2 GHG Emissions — Location-Based (ktCO2e)973 · FY2024
- Scope 1 Direct GHG Emissions — Total (ktCO2e)502 · FY2024
- Scope 1 GHG Emissions — Fuels (ktCO2e)489 · FY2024
- Scope 1 GHG Emissions — Refrigerants & Process Gases (ktCO2e)13 · FY2024
- Scope 1 Stationary Combustion Emissions (ktCO2e)752 · FY2024
- Scope 1 Mobile Fleet Emissions (ktCO2e)129 · FY2024
- Scope 2 Indirect Electricity/Steam GHG Emissions — Market-Based (ktCO2e)393 · FY2024
- Scope 2 Indirect Electricity/Steam GHG Emissions — Location-Based (ktCO2e)472 · FY2024
- Scope 1+2 GHG Emissions — Nutritional Products Division (ktCO2e)325 · FY2024
- Scope 1+2 GHG Emissions — Medical Devices Division (ktCO2e)89 · FY2024
- Scope 1+2 GHG Emissions — Diagnostics Division (ktCO2e)96 · FY2024
- Scope 1+2 GHG Emissions — Established Pharmaceuticals Division (ktCO2e)133 · FY2024
- Scope 1+2 GHG Emissions — Corporate Operations (ktCO2e)251 · FY2024
- Scope 1+2 Market-Based GHG Intensity (tCO2e per $M Sales)21.00 · FY2024
Cite this data
StockData. (2026). Abbott Laboratories Total Scope 1 + Scope 2 Greenhouse Gas Emissions — Market-Based (ktCO2e), annual FY2016–FY2024 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/esg-ghg-s12-mkt
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.